[1]
T. PRABHA and T. SIVAKUMAR, “Drug design and in-silico study of sulphadiazine schiff base analogues for their potential claim as anti-my cobacterial ligand”, ijpbs, vol. 9, no. 3, pp. 106–112, Sep. 2018.